The tumor immune microenvironment and HER2 landscape of high-risk ductal carcinoma in situ: The DEFENSE study

CANCER RESEARCH(2022)

Cited 0|Views19
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined